Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 3/20 | 0.33 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | NOS2 | P35228 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL138698 | 0.86 | — | — | |
| SCHEMBL7321711 | 0.86 | — | — | |
| SCHEMBL18121363 | 0.86 | — | — | |
| SCHEMBL10359041 | 0.78 | CA1 (0.40) | CA1CA2CA4KMT2ACYP2D6 | |
| SCHEMBL14049723 | 0.73 | KMT2A (0.52) | CA1CA2CA4KMT2ACYP2D6 | |
| SCHEMBL11128020 | 0.73 | TSHR (0.50) | CA1CA9TSHRSMN1; SMN2 | |
| SCHEMBL30439306 | 0.73 | TSHR (0.38) | CA1CYP2D6CA9TSHR | |
| SCHEMBL6244171 | 0.70 | — | — | |
| SCHEMBL78237 | 0.70 | — | — | |
| SCHEMBL135300 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4104014-B1 | IMMOBILIZED BUFFERS IN ELECTROACTIVE DEVICES | GENTEX CORP (US) | 2026-04-01 | — | — | EP | disclosed |
| US-12252498-B2 | Electrochromic devices having a buffer system | GENTEX CORPORATION (US) | 2025-03-18 | — | — | US | disclosed |
| EP-4511696-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | GENTEX CORPORATION (US) | 2025-02-26 | — | — | EP | disclosed |
| CN-119032318-A | Electrochromic device with buffer system | 金泰克斯公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-115087920-B | Immobilization buffer in electroactive devices | 金泰克斯公司 | 2024-06-25 | — | — | CN | disclosed |
| US-20230382938-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | GENTEX CORPORATION (US) | 2023-11-30 | — | — | US | disclosed |
| WO-2023205262-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | GENTEX CORPORATION (US) | 2023-10-26 | — | — | WO | disclosed |
| US-11709407-B2 | Immobilized buffers in electroactive devices | GENTEX CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| EP-4104014-A1 | IMMOBILIZED BUFFERS IN ELECTROACTIVE DEVICES | GENTEX CORPORATION (US) | 2022-12-21 | — | — | EP | disclosed |
| CN-115087920-A | Immobilization buffers in electroactive devices | 金泰克斯公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-101857545-A | Synthesis method of single-menthyl | KUNMING YUNDA MEDICINE DEV CO LTD | 2010-10-13 | — | — | CN | disclosed |
| WO-2009089206-A2 | PACKAGING SOLUTIONS | BAUSCH & LOMB INCORPORATED (US) | 2009-07-16 | — | — | WO | disclosed |
| US-20090173045-A1 | Packaging Solutions | LAI YU-CHIN | 2009-07-09 | — | — | US | disclosed |
| WO-2009079224-A2 | SURFACE MODIFIED BIOMEDICAL DEVICES | BAUSCH & LOMB INCORPORATED (US) | 2009-06-25 | — | — | WO | disclosed |
| US-20090156745-A1 | SURFACE MODIFIED BIOMEDICAL DEVICES | LAI YU-CHIN | 2009-06-18 | — | — | US | disclosed |
| CN-101389588-A | Process for making monomenthyl esters | MILLENNIUM SPECIALTY CHEM INC (US) | 2009-03-18 | — | — | CN | disclosed |
| EP-1989169-A2 | PROCESS FOR MAKING MONOMENTHYL ESTERS | Millennium Specialty Chemicals, Inc. (US) | 2008-11-12 | — | — | EP | disclosed |
| WO-2007100450-A2 | PROCESS FOR MAKING MONOMENTHYL ESTERS | MILLENNIUM SPECIALTY CHEMICALS, INC. (US) | 2007-09-07 | — | — | WO | disclosed |
| US-7247743-B1 | Process for making monomenthyl esters | MILLENNIUM SPECIALTY CHEMICALS, INC. (US) | 2007-07-24 | — | — | US | disclosed |
| CN-1971999-A | Electrolytic solution, lithium ion battery containing the same and their preparation method | BYD CO LTD (CN) | 2007-05-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382938-A1 | ELECTROCHROMIC DEVICES HAVING A BUFFER SYSTEM | HCN2, HCN1, HCN3 | CA1 23/4885CA2 66/4885CA4 885/4885 |
| US-12252498-B2 | Electrochromic devices having a buffer system | HCN2, HCN1, HCN3 | CA1 23/4885CA2 66/4885CA4 885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.